With a new titanium biocompatible hardware to minimize priming, three particle platforms for optimal versatility and eight particle chemistries to maximize selectivity and sensitivity, bioZen UHPLC/HPLC columns are seamlessly designed to bring peace of mind to your analysis of biologics through:
Aggregate Analysis, Peptide Mapping, Charge Variant Analysis, Intact Mass, Intact and Fragment Analysis, Glycan Analysis, Peptide Quantitation, and Drug Antibody Ratio (DAR).
Phenomenex to be Acquired by Danaher Corporation
Phenomenex Inc. announced it has signed a definitive agreement to be acquired by Danaher Corporation. Phenomenex will operate as a standalone operating company, retaining the Phenomenex brand, its personnel and site locations. "Phenomenex is a widely recognizable brand that we are proud to ... more
Phenomenex Opens New Office in India
Phenomenex Inc. announced that it has expanded its international subsidiary network to serve India directly from a new office in Hyderabad. The new entity, which opened this month, will serve research communities throughout India with sales and service teams that sell all Phenomenex produc ... more
Phenomenex announced that president and CEO Fasha Mahjoor has been selected as a finalist for Ernst & Young's Greater Los Angeles Entrepreneur of the Year 2010 award. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the ar ... more
